Welwyn Garden City, UK – 5th February 2013 – Cresset, innovative provider of chemistry software and services, announces Field Based Chemistry Europe 2013 and Field Based Chemistry North America 2013, two scientific meetings on the use of fields in the design and discovery of small molecules.
The events are of interest to researchers who want to: make the best possible compounds; shorten optimization processes; create or improve IP position by patent-busting or patent expansion; generate new leads, even in crowded therapeutic areas; develop lower-risk and lower-cost strategies for the discovery of new chemical entities.
Dr Robert Scoffin, CEO at Cresset says, “The Field Based Chemistry meetings build on our previous successful user group meetings. This year we look forward to welcoming individuals from commercial, research and academic organizations who are keen to explore what makes Cresset’s software and services unique.”
Field Based Chemistry North America 2013 takes place on May 14 at Novartis Institutes for BioMedical Research, Cambridge, MA. Speakers include Dr Patrick McCarren from The Broad Institute. Scientists and researchers are invited to submit abstracts for oral presentations by March 15, 2013. The meeting is offered free to delegates. http://www.cresset-group.com/fbcna2013/
Field Based Chemistry Europe is on June 20 to 21 at Madingley Hall, Cambridge, UK. Scientists and researchers are invited to submit abstracts for oral presentations and posters by March 15, 2013. The meeting is offered free to delegates. http://www.cresset-group.com/fbce2013/
About Cresset Group Ltd
Cresset develops software for calculating and comparing the molecular field characteristics of chemical compounds. Cresset also offers consultancy services which enable companies to outsource computational chemistry work to achieve high value, on-demand expertise, particularly in the areas of library design, virtual screening, scaffold hopping, lead optimization and patent analysis.
Cresset’s field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. This field technology provides a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com